Clinical trial
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma: A Multicenter Randomized Controlled Study
NCT07248956 is registered in ClinicalTrials.gov with Eye & ENT Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma: A Multicenter Randomized Controlled Study
- Lead sponsor
- Eye & ENT Hospital of Fudan University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- December 22, 2025
- Completion date
- December 30, 2029
- Enrollment
- 116 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
hypopharyngeal carcinoma